Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

Omega Pharma sells 24.04% interest in Arseus for between 8.00 euro and a maximum of 10.75 euro per share


Print article Print article
Refer this article Refer to a friend
Copyright © Hugin AS 2009. All rights reserved.
2009-11-09 07:34:04 -


London, November , 09, 2009
WATERLAND BECOMES REFERENCE SHAREHOLDER IN ARSEUS

Waregem (Belgium), 9  November 2009  (07:30 CET) -  Omega Pharma  NV,
Arseus NV  and  Waterland Private  Equity  Investments  ('Waterland')
jointly announce  today  that  Waterland  has  signed  agreements  to
purchase a minority 25.10% interest  in Arseus. Via its fourth  fund,
Waterland will purchase 7,500,000  shares (24.04%) from Omega  Pharma
and 330,000  shares (1.06%)  from  Couckinvest NV  at 8.00  euro  per
Arseus share, plus an earn-out of up to 2.75 euro per share,  payable
when Waterland  exits,  depending  on the  future  shareholder  value
created by Arseus.  Completion of  the transaction  is scheduled  for
25 November 2009.

Arseus, the  former Professional  Health  Division of  Omega  Pharma,
became an independent entity on 5 October 2007 via an IPO. After  the
IPO, Omega Pharma held 7,500,000 Arseus shares or 24.04% of the total
shares in issue.

Based on the denominator of  31,195,121 (total number of shares)  and
the relevant  notifications  received  by  Arseus,  the  shareholding
structure after completion of the transaction will be as follows:


+-------------------------------------------------------------------+
| Arseus                   | Number of shares | Percentage of total |
|--------------------------+------------------+---------------------|
| Waterland Private Equity |        7,830,000 |              25.10% |
| Fund IV CV               |                  |                     |
|--------------------------+------------------+---------------------|
| Couckinvest NV / Coucke  |        3,528,080 |              11.31% |
|--------------------------+------------------+---------------------|
| Fortis Investment        |        2,756,357 |               8.84% |
| Management SA            |                  |                     |
|--------------------------+------------------+---------------------|
| Arseus NV (treasury      |          973,915 |               3.12% |
| shares)                  |                  |                     |
|--------------------------+------------------+---------------------|
| Public                   |       16,106,769 |              51.63% |
+-------------------------------------------------------------------+



Please open the link below for the full press release:

hugin.info/138311/R/1353496/327854.pdf


This announcement was originally distributed by Hugin. The issuer is 
solely responsible for the content of this announcement.


Disclaimer: © 2009 Hugin. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Hugin's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Terms & Conditions | Privacy | About us | Contact PR-inside.com